Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DSGN
DSGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DSGN News
Design Therapeutics to Announce FA Trial Data on May 18, 2026
May 17 2026
Newsfilter
Investor Perspectives on Silicon Motion and BillionToOne
May 15 2026
CNBC
RESTORE-FA Trial Progressing Well with Promising Data Expected
Apr 29 2026
Yahoo Finance
Design Therapeutics Reports Q1 2026 Financial Results and Milestones
Apr 29 2026
NASDAQ.COM
Design Therapeutics Q4 Earnings Beat Expectations
Mar 09 2026
seekingalpha
FibroBiologics (FBLG) Stock Rises 7.68%, Attracts Market Attention
Jan 13 2026
NASDAQ.COM
Significant Options Trading on Wednesday: UTHR, URGN, DSGN
Dec 17 2025
NASDAQ.COM
Design Therapeutics to Participate in Two Investor Conferences
Nov 26 2025
Globenewswire
Nutex Health Reports Impressive Q3 Performance, Partners with PACS Group, While Walmart, Cerence, and Other Major Stocks Rise on Thursday
Nov 20 2025
Benzinga
Steven Cohen's Biotech Investments Are Becoming More Ambitious Yet More Focused
Aug 29 2025
Benzinga
Design Therapeutics to Present Phase 1 Data for Fuchs Endothelial Corneal Dystrophy Program at Eyecelerator @ Park City 2025
Apr 21 2025
Yahoo Finance
Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
Apr 16 2025
Globenewswire
Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results
Mar 10 2025
Newsfilter
Sangamo Therapeutics, Dave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Dec 31 2024
Benzinga
Why Cemtrex Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Dec 31 2024
Benzinga
Lamb Weston Posts Weak Q2 Results, Joins Micron, Lennar And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Dec 19 2024
Benzinga
Show More News
